Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
    • CFP AI policy
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums

User menu

  • My alerts

Search

  • Advanced search
The College of Family Physicians of Canada
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums
  • My alerts
The College of Family Physicians of Canada

Advanced Search

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
    • CFP AI policy
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • RSS feeds
  • Follow cfp Template on Twitter
  • LinkedIn
  • Instagram
Article CommentaryCommentary

From methadone to Methadose

Lessons learned from methadone formulation change in British Columbia

Matias Raski, Christy Sutherland and Rupinder Brar
Canadian Family Physician November 2020; 66 (11) 797-798;
Matias Raski
Medical student at the University of British Columbia in Vancouver.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christy Sutherland
Clinical Assistant Professor in the Faculty of Medicine at the University of British Columbia and Education Physician Lead with the British Columbia Centre on Substance Use.
MD CCFP(AM)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rupinder Brar
Clinical Assistant Professor in the Faculty of Medicine at the University of British Columbia.
MD CCFP(AM)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rupinder.brar5{at}vch.ca
  • Article
  • eLetters
  • Info & Metrics
  • PDF
Loading
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson{at}gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

Jump to comment:

  • RE: From methadone to Methadose
    Denise J. Denning
    Published on: 17 January 2021
  • Published on: (17 January 2021)
    Page navigation anchor for RE: From methadone to Methadose
    RE: From methadone to Methadose
    • Denise J. Denning, Pharmacist, Ontario Correctional Services

    As a pharmacist who has been dispensing methadone for more than twenty years to patients in and out of Ontario provincial jails, I read this article with interest (and gratitude to one of the MDs on our team, who thoughtfully clipped this article out of his paper copy of your journal and provided it to me). When we transitioned from methadone to Methadose in Ontario, I braced myself for patients' reactions and prepared from some sort of backlash. What I found after the transition was that many of our patients started hearing about the complaints from people receiving methadone in British Columbia. But here in Ontario, my patients did not have this same experience.

    The article doesn't really address in detail the main change that occurred with this transition, and issues that may arise from it: that all pharmacists in the country were compelled to stop making stock solutions from methadone powder and use the commercial product instead. I suggest the possibility that the issue with the transition to Methadose arises from the precision with which doses of methadone were formerly being prepared. The reason that provincial regulators decided to enforce Health Canada’s Policy on Manufacturing and Compounding Drug Products in Canada (2009), and compel pharmacists to stop preparing methadone solution in the back of our pharmacies was that, regardless of our level of skill, precision, and professionalism, we do not have the same degree of quality control in our pha...

    Show More

    As a pharmacist who has been dispensing methadone for more than twenty years to patients in and out of Ontario provincial jails, I read this article with interest (and gratitude to one of the MDs on our team, who thoughtfully clipped this article out of his paper copy of your journal and provided it to me). When we transitioned from methadone to Methadose in Ontario, I braced myself for patients' reactions and prepared from some sort of backlash. What I found after the transition was that many of our patients started hearing about the complaints from people receiving methadone in British Columbia. But here in Ontario, my patients did not have this same experience.

    The article doesn't really address in detail the main change that occurred with this transition, and issues that may arise from it: that all pharmacists in the country were compelled to stop making stock solutions from methadone powder and use the commercial product instead. I suggest the possibility that the issue with the transition to Methadose arises from the precision with which doses of methadone were formerly being prepared. The reason that provincial regulators decided to enforce Health Canada’s Policy on Manufacturing and Compounding Drug Products in Canada (2009), and compel pharmacists to stop preparing methadone solution in the back of our pharmacies was that, regardless of our level of skill, precision, and professionalism, we do not have the same degree of quality control in our pharmacies as does Big Pharma, and mishaps, though rare, did happen. Much as it behooves me to say so, the possibility exists that the extemporaneously prepared doses of methadone did not contain the same amount of methadone as when we started using the more precisely prepared commercial product. And this dose discrepancy perhaps was for some reason most extreme in British Columbia. Otherwise, why did we barely experience this problem in Ontario?

    Though there may be another explanation that arises from an examination of the entire context of illicit drug use and what drugs are available on the illicit market, and how those may affect patients. Specifically, the roll-out of Methadose in 2014 happened to coincide with the increasing presence of fentanyl in the heroin supply. Most people in opioid agonist treatment programs continue to use illicitly-acquired drugs. If people who use opioids start unknowingly receiving fentanyl, and they persist with this use and don't overdose from fentanyl's 50-fold potency compared with heroin, their physical tolerance to opioids will increase, ergo their usual dose of methadone will not be sufficient to suppress their opioid cravings. And since Vancouver is a port city, people who use opioids were likely to encounter fentanyl before most of the rest of the country. And yes; fentanyl has now unfortunately spread throughout Canada, but as it arrived in more inland cities, perhaps it more gradually supplanted other illicit drug sources than happened in Vancouver, so the tolerance of patients was more gradually affected. After all, back in the Oxycontin days, Oxycontin was the most trafficked opioid in Canada with the exception of two port cities: Montreal, and yes, Vancouver, where heroin remained the most prevalent opioid of illicit use until fentanyl came along.

    I agree with your points regarding more community consultation. People with substance use disorder are amongst the most vulnerable of our citizens, and they especially don't like changes being imposed upon them without negotiation or discussion. But methadone is methadone, and it doesn't make any sense that there would be any difference. I appreciate your thoroughness of examining whether there was any pharmaceutical difference between formulations. I suggest that this problem encountered by some patients may have a more substantiative explanation, but given the impossibility of comparing the extemporaneously prepared doses made before 2014 with the current doses, and the complexity of determining the effects of the illicit drug supply on our patients, I don't know if this is a mystery we will ever solve.

    Show Less
    Competing Interests: None declared.
PreviousNext
Back to top

In this issue

Canadian Family Physician: 66 (11)
Canadian Family Physician
Vol. 66, Issue 11
1 Nov 2020
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on The College of Family Physicians of Canada.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
From methadone to Methadose
(Your Name) has sent you a message from The College of Family Physicians of Canada
(Your Name) thought you would like to see the The College of Family Physicians of Canada web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
From methadone to Methadose
Matias Raski, Christy Sutherland, Rupinder Brar
Canadian Family Physician Nov 2020, 66 (11) 797-798;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
From methadone to Methadose
Matias Raski, Christy Sutherland, Rupinder Brar
Canadian Family Physician Nov 2020, 66 (11) 797-798;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • A new solution?
    • Seeking understanding of change intolerance
    • Proceed with caution
    • Footnotes
    • References
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • De la méthadone à la Méthadose
  • PubMed
  • Google Scholar

Cited By...

  • Methadone is methadone
  • Google Scholar

More in this TOC Section

  • Diving deep in the undergraduate medical education curriculum
  • Top influences and concerns of residents selecting a career in family medicine
  • Navigating Canada’s primary care crisis
Show more Commentary

Similar Articles

Navigate

  • Home
  • Current Issue
  • Archive
  • Collections - English
  • Collections - Française

For Authors

  • Authors and Reviewers
  • Submit a Manuscript
  • Permissions
  • Terms of Use

General Information

  • About CFP
  • About the CFPC
  • Advertisers
  • Careers & Locums
  • Editorial Advisory Board
  • Subscribers

Journal Services

  • Email Alerts
  • Twitter
  • LinkedIn
  • Instagram
  • RSS Feeds

Copyright © 2025 by The College of Family Physicians of Canada

Powered by HighWire